JNCE

Jounce Therapeutics, Inc. Common Stock
JNCE

Overview Fund Activity
Delisted

JNCE was delisted on the 3rd of May, 2023.

Back to rankings

124 hedge funds and large institutions have $343M invested in Jounce Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 14 closing their positions.

Holders
124
Holders Change
+9
Holders Change %
+7.83%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
37
Reduced
36
Closed
14
Calls
$396K
Puts
$1K
Net Calls
+$395K
Net Calls Change
+$5K

Top Buyers

1
RI
1
RTW Investments
New York
$23.9M
2
WP
2
Woodline Partners
California
$11.4M
3
SI
3
Sofinnova Investments
California
$13.2M
4
Barclays
4
Barclays
United Kingdom
$6M
5
ABG
5
Ally Bridge Group
New York
$4.8M

Top Sellers

1
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$0
2
TGI
2
TRV GP III
Massachusetts
$9.59M
3
LGM
3
Logos Global Management
California
$11.3M
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$2.89M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$85K
Name Holding Trade Value Shares
Change 		Shares
Change %
Two Sigma Investments
26
Two Sigma Investments
New York
$2.66M +$799K +95,648 +43%
MSAM
27
Moloney Securities Asset Management
Missouri
$2.64M +$283K +33,925 +12%
OFM
28
Omega Fund Management
Massachusetts
$2.3M – – –
Jacobs Levy Equity Management
29
Jacobs Levy Equity Management
New Jersey
$2.23M +$2.23M +267,032 New
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$2.2M -$238K -28,532 -10%
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$2.12M +$2.12M +253,931 New
SCM
32
Silverarc Capital Management
Massachusetts
$2.05M +$311K +37,270 +18%
Assenagon Asset Management
33
Assenagon Asset Management
Luxembourg
$1.78M -$200 -24 -0%
Connor, Clark & Lunn Investment Management (CC&L)
34
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.46M +$450K +53,840 +45%
GIM
35
Granahan Investment Management
Massachusetts
$1.41M -$48K -5,751 -3%
AQR Capital Management
36
AQR Capital Management
Connecticut
$1.35M -$48.1K -5,766 -3%
SSA
37
Schonfeld Strategic Advisors
New York
$1.29M +$312K +37,406 +32%
Mariner
38
Mariner
Kansas
$1.21M -$39.4K -4,714 -3%
Charles Schwab
39
Charles Schwab
California
$1.2M +$777 +93 +0.1%
YMRC
40
Yorktown Management & Research Company
Virginia
$1.15M +$201K +24,100 +21%
Nuveen Asset Management
41
Nuveen Asset Management
Illinois
$1.14M -$28.2K -4,023 -2%
ACP
42
Acuta Capital Partners
California
$1.07M +$1.07M +127,500 New
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.06M -$8.98K -1,074 -0.8%
PAM
44
Panagora Asset Management
Massachusetts
$944K +$61.5K +7,369 +7%
Ameriprise
45
Ameriprise
Minnesota
$895K +$895K +107,198 New
Allspring Global Investments
46
Allspring Global Investments
North Carolina
$657K +$657K +78,694 New
AI
47
Atom Investors
Texas
$640K +$640K +76,639 New
Millennium Management
48
Millennium Management
New York
$581K -$1.43M -171,685 -71%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$574K +$287K +34,388 +100%
Wells Fargo
50
Wells Fargo
California
$564K -$1.04M -124,231 -65%
1
2
3 4 5